A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/14/2006	US20060281804 N-Benzyl-2,3,4,9-tetrahydrocarbazole-1-amine hydrochloride salt, for the treatment of human papillomaviruses infection, genital warts, or cervical dysplasia
12/14/2006	US20060281803 Pyrazole modulators of metabotropic glutamate receptors
12/14/2006	US20060281802 3-(4-{2-[5-phenyl-2-(trifluoromethyl)-1H-benzimidazol-1-yl]ethoxy}phenyl)-2-ethoxypropanoic acid; can be coadministered with another antidiabetic agent, anticholesterol agent, hypoglycemic agent, or enzyme inhibitor
12/14/2006	US20060281801 Process for the preparation of valsartan and its intermediates
12/14/2006	US20060281800 Polymorphic form of olmesartan and process for its preparation
12/14/2006	US20060281799 8-({5-[4-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl}amino)-3,4-dihydronaphthalen-2(1H) one; treating pain, bladder overactivity, and urinary incontinence
12/14/2006	US20060281798 Methods of using thiazolidinedithione derivatives
12/14/2006	US20060281797 Neurorestoration with R(+) Pramipexole
12/14/2006	US20060281796 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/14/2006	US20060281795 Benzinidazole Derivative and Use As AII Receptor Antagonist
12/14/2006	US20060281794 Erg channel openers for the treatment of cardiac arrhythmias
12/14/2006	US20060281793 Pharmaceutical composition for the management of tumors
12/14/2006	US20060281791 Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
12/14/2006	US20060281790 combination comprising as active ingredients an AT1-receptor antagonist or a pharmaceutically acceptable salt thereof, an insulin secretion enhancer or a pharmaceutically acceptable salt thereof, or an insulin sensitizer or a pharmaceutically salt thereof and a carrier; valsartan; diabetes treatment
12/14/2006	US20060281789 Protein kinase inhibitors
12/14/2006	US20060281788 Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
12/14/2006	US20060281787 Bisindolyl maleimides useful for treating prostate cancer and akt-mediated diseases
12/14/2006	US20060281786 Compounds having activity at 5ht2c receptor and uses thereof
12/14/2006	US20060281785 Compound artemisinin
12/14/2006	US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/14/2006	US20060281783 Compositions and methods of treating middle-of-the night insomnia
12/14/2006	US20060281782 Method for the enantioselective preparation of sulphoxide derivatives
12/14/2006	US20060281781 Preventive and therapeutic medicament for gastroesophageal reflux disease
12/14/2006	US20060281779 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE
12/14/2006	US20060281778 Compounds for inhibiting KSP Kinesin activity
12/14/2006	US20060281777 Process for preparing crystalline form I of cabergoline
12/14/2006	US20060281776 Isotope labeled camptothecin derivatives
12/14/2006	US20060281775 Two-component pharmaceutical composition for the treatment of pain
12/14/2006	US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/14/2006	US20060281773 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/14/2006	US20060281772 Alkylquinoline and alkylquinazoline kinase modulators
12/14/2006	US20060281771 Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
12/14/2006	US20060281770 Method of treating an anxiety disorder
12/14/2006	US20060281769 Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
12/14/2006	US20060281768 Thienopyrimidine and thienopyridine kinase modulators
12/14/2006	US20060281767 Triazoloypyrimidines
12/14/2006	US20060281764 Aminopyrimidines as kinase modulators
12/14/2006	US20060281763 Carboxamide inhibitors of TGFbeta
12/14/2006	US20060281762 1,3-Benzoxazolyl derivatives as kinase inhibitors
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281760 Tubulin inhibitor and process for its preparation
12/14/2006	US20060281759 selective serotonin receptor antagonists used for the treatment of psychological disorders such as schizophrenia and bipolar disorders, as anxiolytic agents and antidepressants; improved water solubility; side effect reduction;
12/14/2006	US20060281758 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
12/14/2006	US20060281757 Phenyl sulfone derivatives and their use in the treatment of cns disorders
12/14/2006	US20060281756 Synthesis of 3-amino-4-substituted pyrazole derivatives
12/14/2006	US20060281755 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
12/14/2006	US20060281754 Method of treating liver disease
12/14/2006	US20060281753 4-(Aminomethyl)-piperidine benzamides as 5ht4 - antagonists
12/14/2006	US20060281752 Method for the normalization of sexual response and amelioration of long term genital tissue degradation
12/14/2006	US20060281751 Raf inhibitor compounds and methods of use thereof
12/14/2006	US20060281750 3-Cycloheptyl-8-((2,6-dichlorophenoxy)methyl)H-imidazo[1,5-a]pyridine; N-((3-((2,6-Dichlorophenoxy)methyl)pyridin-2-yl)methyl)cycloheptane-carboxamide; diabetes; cardiovascular diseases, Metabolic Syndrome, inflammatory diseases
12/14/2006	US20060281749 Method for treating glaucoma IV B
12/14/2006	US20060281748 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
12/14/2006	US20060281747 1,2-di(cyclic) substituted benzene derivatives
12/14/2006	US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
12/14/2006	US20060281745 Use of pde4 inhibitors for the treatment of diabetes mellitus
12/14/2006	US20060281744 e.g. 5-(4-tert-Butylbenzenesulfonylamino)-3-phenyl- 1 -benzothiophene-2-carboxylic acid-(2-hydroxypropyl)amide; contraceptive; for male fertility control; act on testicular stem cells and mature sperm
12/14/2006	US20060281743 Isoquinolinone potassium channel inhibitors
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281741 Therapy for bacteria infections other than Myconacterium infections; antibiotic resistance
12/14/2006	US20060281740 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
12/14/2006	US20060281739 Compositions and methods for treatment of eye disorders
12/14/2006	US20060281738 2-Naphthylimino-1,3-thiazine derivative
12/14/2006	US20060281737 Cyclohexyl sulphones as gamma-secreatase inhibitors
12/14/2006	US20060281736 Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
12/14/2006	US20060281735 Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
12/14/2006	US20060281732 4-[(3-aminopropyl) (ethyl)amino]-2-{[1-(carboxymethyl)-2-oxo-2, 3, 4, 5-tetrahydro-1H-1benzazepin-3-yl]amino}carbonyl)-cyclopentyl]methyl}-4-oxobutanoic acid; neutral endopeptidase or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis, stroke, neurodegenerative disorder
12/14/2006	US20060281731 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells
12/14/2006	US20060281730 beta secretase inhibitors, used to treat cardiovascular diseases, cognitive and neurodegenerative diseases
12/14/2006	US20060281729 Macrocyclic heterocyclic aspartyl protease inhibitors
12/14/2006	US20060281728 3-Substituted beta-lactamyl vasopressin v1a antagonists
12/14/2006	US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
12/14/2006	US20060281726 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
12/14/2006	US20060281725 Agents and crystals for improving excretory potency of urinary bladder
12/14/2006	US20060281724 Methods for Treating Shock
12/14/2006	US20060281723 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
12/14/2006	US20060281722 Compounds and uses thereof
12/14/2006	US20060281721 HRT formulations
12/14/2006	US20060281720 5-Androstenediol As An Inhibitor of Gliomas
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281718 Treatment of VR1-antagonist-induced increase in body temperature with an antipyretic agent
12/14/2006	US20060281717 11a, 12-derivatives of tetracycline compounds
12/14/2006	US20060281716 Alkaloid formulations
12/14/2006	US20060281715 Phosphates of secondary alcohols
12/14/2006	US20060281714 Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
12/14/2006	US20060281713 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the alkyl ester; glaucoma, intraocular hypotensive agents
12/14/2006	US20060281712 Pyrimidine compounds
12/14/2006	US20060281711 2-Morpholin-4-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or immune-mediated diabetes mellitus
12/14/2006	US20060281710 17SS-HSD1 and STS inhibitors
12/14/2006	US20060281709 Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phosphate as active ingredient
12/14/2006	US20060281708 Fluorinated glucosamine analogs useful for modulating post-translational glyscosylations on cells
12/14/2006	US20060281707 N-acetyl-D-glucosamine or salts thereof in the manufacture of a medicament for treating organ lesions caused by toxicants and drugs; simple manufacture and has no side effect
12/14/2006	US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral
12/14/2006	US20060281705 A1 adenosine receptor agonists
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281700 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
12/14/2006	US20060281699 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/14/2006	US20060281696 Decoy-oligonucleotide-inhibition of cd40-expression

1 ... 3966 3967 3968 3969 3970 3971 3972 3973 3974 3975 3976 3977 3978 3979 3980 3981 3982 3983 3984 3985 3986 ... 7860